Clinical trial AI platform with real-world evidence capabilities
HEALWELL AI operates a physician-led healthcare AI platform focused on early disease detection and preventative care. The tech stack reveals a clinical-grade operation: LC-MS/MS (laboratory analysis), Azure infrastructure, Databricks for data pipelines, and CDISC compliance tooling — indicating active clinical trial execution rather than consumer health apps. Hiring velocity is accelerating across data, engineering, and healthcare roles, with active projects spanning MLOps maturity, AI platform security, and patient identification workflows — pointing toward a scaling phase in regulatory-grade AI infrastructure.
Notable leadership hires: Commercial Director, Account Director
HEALWELL AI is a Toronto-based, publicly traded healthcare technology company (TSX: AIDX) with 201–500 employees. The organization develops AI and data science solutions for early disease identification and preventative care, operating at the intersection of clinical research and digital health. The project list — clinical study databases, phase I/bioequivalence programs, eCRF design, and real-world evidence pipelines — indicates direct involvement in clinical trial execution and drug development workflows. Leadership is clinician-informed, with a management team of experienced healthcare executives. Current scaling challenges center on data quality in trials, compliance (security, IFRS financial reporting), and automation of manual execution workflows.
LC-MS/MS for laboratory analysis, Azure cloud, Databricks for data engineering, Terraform for infrastructure, CDISC standards for clinical data, NetSuite for financials, and Microsoft Office suite for operations.
Clinical trial infrastructure including study databases, patient identification workflows, eCRF design, phase I bioequivalence programs, MLOps maturity roadmap, and AI platform security and scalability for compliance.
Other companies in the same industry, closest in size